You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2026

AbstractFullPdf
May 202024324351
Jun 2020296296104
Jul 202011911934
Aug 202010810636
Sep 202015315362
Oct 202011211242
Nov 202010410433
Dec 202011211253
Jan 202112812836
Feb 202112212250
Mar 202116316355
Apr 202112712744
May 2021878735
Jun 202110210245
Jul 2021767634
Aug 2021828239
Sep 2021858549
Oct 202112212276
Nov 2021919167
Dec 2021959540
Jan 20229610540
Feb 2022687541
Mar 202213716391
Apr 202216418586
May 202213515286
Jun 20229910656
Jul 2022849544
Aug 2022789168
Sep 20228799188
Oct 2022808553
Nov 2022889271
Dec 2022656929
Jan 2023747652
Feb 202311612144
Mar 2023879043
Apr 2023748450
May 2023899841
Jun 2023576127
Jul 2023939540
Aug 202310610775
Sep 2023636434
Oct 2023686847
Nov 2023757542
Dec 202310810852
Jan 2024556220
Feb 2024818241
Mar 2024788378
Apr 2024838572
May 2024767741
Jun 2024616539
Jul 2024878830
Aug 2024929357
Sep 20246163397
Oct 2024636438
Nov 2024737433
Dec 2024697037
Jan 2025848547
Feb 2025454523
Mar 2025909044
Apr 202510510658
May 2025888855
Jun 2025363626
Jul 2025110
Feb 2026110
Total604762473521